Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma. Jan 2011 - Blood; 117(2):1528-0020 [PMID:21030562] [Rosenblatt J] [Vasir B] [Uhl L] [Blotta S] [Macnamara C] [Somaiya P] [Wu Z] [Joyce R] [Levine JD] [Dombagoda D] [Yuan YE] [Francoeur K] [Fitzgerald D] [Richardson P] [Weller E] [Anderson K] [Kufe D] [Munshi N] [Avigan D]
Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28. Feb 2010 - :1537-4513 [PMID:20145548] [Rosenblatt J] [Wu Z] [Vasir B] [Zarwan C] [Stone R] [Mills H] [Friedman T] [Konstantinopoulos PA] [Spentzos D] [Ghebremichael M] [Stevenson K] [Neuberg D] [Levine JD] [Joyce R] [Tzachanis D] [Boussiotis V] [Kufe D] [Avigan D]
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells. Jun 2008 - J. Immunol.; 181(1):0022-1767 [PMID:18566447] [Vasir B] [Wu Z] [Crawford K] [Rosenblatt J] [Zarwan C] [Bissonnette A] [Kufe D] [Avigan D]
Dendritic cell defects in patients with cancer: mechanisms and significance. Mar 2006 - Breast Cancer Res.; 8(1):1465-542X [PMID:16469120] [Lenahan C] [Avigan D]
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Jul 2004 - Clin. Cancer Res.; 10(14):1078-0432 [PMID:15269142] [Avigan D] [Vasir B] [Gong J] [Borges V] [Wu Z] [Uhl L] [Atkins M] [Mier J] [McDermott D] [Smith T] [Giallambardo N] [Stone C] [Schadt K] [Dolgoff J] [Tetreault JC] [Villarroel M] [Kufe D]
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma. Apr 2004 - Br. J. Haematol.; 125(3):0007-1048 [PMID:15086415] [Raje N] [Hideshima T] [Davies FE] [Chauhan D] [Treon SP] [Young G] [Tai YT] [Avigan D] [Gong J] [Schlossman RL] [Richardson P] [Kufe DW] [Anderson KC]
Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Mar 2002 - Blood; 99(7):0006-4971 [PMID:11895787] [Gong J] [Koido S] [Chen D] [Tanaka Y] [Huang L] [Avigan D] [Anderson K] [Ohno T] [Kufe D]
